Processing

Please wait...

Settings

Settings

Goto Application

1. WO2012065025 - PROSTATE CANCER POINT OF CARE DIAGNOSTICS

Publication Number WO/2012/065025
Publication Date 18.05.2012
International Application No. PCT/US2011/060307
International Filing Date 11.11.2011
IPC
G01N 33/574 2006.01
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
574for cancer
G01N 33/48 2006.01
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
CPC
C40B 40/10
CCHEMISTRY; METALLURGY
40COMBINATORIAL TECHNOLOGY
BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICO LIBRARIES
40Libraries per se, e.g. arrays, mixtures
04Libraries containing only organic compounds
10Libraries containing peptides or polypeptides, or derivatives thereof
G01N 33/54386
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
543with an insoluble carrier for immobilising immunochemicals
54366Apparatus specially adapted for solid-phase testing
54386Analytical elements
G01N 33/57434
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
574for cancer
57407Specifically defined cancers
57434of prostate
G01N 33/689
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68involving proteins, peptides or amino acids
689related to pregnancy or the gonads
Applicants
  • WILLIAM MARSH RICE UNIVERSITY [US]/[US] (AllExceptUS)
  • UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER [US]/[US] (AllExceptUS)
  • MCDEVITT, John T. [US]/[US] (UsOnly)
  • CHRISTODOULIDES, Nicolaos [US]/[US] (UsOnly)
  • FLORIANO, Pierre N. [US]/[US] (UsOnly)
  • THOMPSON, Ian [US]/[US] (UsOnly)
Inventors
  • MCDEVITT, John T.
  • CHRISTODOULIDES, Nicolaos
  • FLORIANO, Pierre N.
  • THOMPSON, Ian
Agents
  • VALOIR, Tamsen V.
Priority Data
61/412,99412.11.2010US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) PROSTATE CANCER POINT OF CARE DIAGNOSTICS
(FR) DIAGNOSTIC SUR LES LIEUX DE SOIN DU CANCER DE LA PROSTATE
Abstract
(EN)
The invention relates to point of care diagnostic disposables, devices, methods, and systems for diagnosing or predicting prostate cancer. The present invention employs biomarker specific reagents in disposable cassettes or lab cards for use as analyzers, as well as software to evaluate and report test results. The system promises to improve point of care in vitro diagnostics.
(FR)
L'invention concerne des produits jetables, des dispositifs, des procédés et des systèmes de diagnostic sur les lieux de soin pour le diagnostic ou la prédiction du cancer de la prostate. La présente invention utilise des réactifs spécifiques de biomarqueur dans des cassettes ou des laboratoires-sur-puce jetables pour l'utilisation en tant qu'analyseurs, ainsi que des logiciels pour évaluer et rapporter les résultats d'essai. Le système permet d'améliorer le diagnostic in vitro sur les lieux de soin.
Also published as
Latest bibliographic data on file with the International Bureau